Lynch Healthcare Limited

	Page
Balance Sheet	1
Notes to the Financial Statements	2—3

Registered number: 06863318

		2025		2024
	Notes	£	£	£	£
CURRENT ASSETS
Stocks	4	53,947		53,947

		53,947		53,947
Creditors: Amounts Falling Due Within One Year	5	(34,838 )		(34,838 )

NET CURRENT ASSETS (LIABILITIES)			19,109		19,109

TOTAL ASSETS LESS CURRENT LIABILITIES			19,109		19,109

Creditors: Amounts Falling Due After More Than One Year	6		(155,104 )		(155,104 )

NET LIABILITIES			(135,995 )		(135,995 )

CAPITAL AND RESERVES
Called up share capital	7		100		100
Profit and Loss Account			(136,095 )		(136,095 )

SHAREHOLDERS' FUNDS			(135,995)		(135,995)

For the year ending 31 December 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

On behalf of the board

J E Keenlyside

Director

03/06/2026

The notes on pages 2 to 3 form part of these financial statements.

1. General Information

Lynch Healthcare Limited is a private company limited by shares, and incorporated in England and Wales. Its registered company number is 06863318, and its registered address is Unit 8 Withey Court, Western Industrial Estate, Caerphilly, Mid Glamorgan, United Kingdom, CF83 1BF.

The financial statements are prepared in Sterling, which is the functional currency of the Company. Monetary amounts in these financial statements are rounded to the nearest £1.

The principal activity of the company is that of a dormant company.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 101, “Reduced Disclosure Framework” and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 101 requires the use of certain critical accounting estimates. It also requires management to exercise judgement in applying the company’s accounting policies (see note 3).

2.2. Stocks and Work in Progress

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in. first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks ate impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

3. Average Number of Employees

Average number of employees, including directors, during the year was: NIL (2024: NIL)

4. Stocks

	2025	2024
	£	£
Stock	53,947	53,947

5. Creditors: Amounts Falling Due Within One Year

	2025	2024
	£	£
Accruals and deferred income	34,838	34,838

6. Creditors: Amounts Falling Due After More Than One Year

	2025	2024
	£	£
Bank loans	155,104	155,104

7. Share Capital

	2025	2024
	£	£
Allotted, Called up and fully paid	100	100

Page 2

Page 3

Lynch Healthcare Limited

Notes to the Financial Statements (continued)

For The Year Ended 31 December 2025

8. Post Balance Sheet Events

On 30th January 2026, Rhône, a global private equity firm, completed the acquisitions of Invacare Holdings SARL (Invacare Europe and APAC) and its subsidiaries and DHG Holdco SARL and its subsidiaries, combining the businesses and associated brands to create DHCare, with the aim to be one of the international leaders in designing, manufacturing and distributing medical devices in the mobility and post-acute care sectors. Archimed have also retained a minority share in the newly combined business.

Page 3